Participant demographics and clinical characteristics | Â | Â |
N | 142 | |
Female, n (%) | 87 (61%) | |
Age, median years (IQR) | 32 (28, 38) | |
Weight, median kg (IQR) | 46 (41, 51) | |
BMI, median kg/m2 (IQR) | 16 (15, 19) | |
CD4+count, median cells/mm3L (IQR) | 34 (21, 47) | |
Hemoglobin, median g/dL (IQR) | 9.8 (8.8, 11.6) | |
Baseline serum biomarker levels | Â | Â |
Phosphate, median mmol/L (IQR) | 1.26 (1.03, 1.42) | [range 0.4-2.3] |
Albumin, median g/L (IQR) | 29.5 (23.9, 33.2) | [range 13.1-49.5] |
Ferritin, median μg/L (IQR) | 221 (59, 485) | [range 4-1332] |
hsCRP, median mg/L (IQR) | 2.8 (1.1, 15.2) | [range 0.2-58.3] |
ART regimen, n (%) | Â | Â |
   ZDV/3TC/EFV | 8 (6%) | |
   ZDV/3TC/NVP | 34 (24%) | |
   d4T/3TC/EFV | 15 (11%) | |
   d4T/3TC/NVP | 62 (44%) | |
   TDF/FTC/EFV | 4 (3%) | |
   TDF/FTC/NVP | 19 (13%) |